Gludantan

Gludantan, or gludantane, is an experimental antiparkinsonian agent of the aminoadamantane group that was never marketed.^[1][2] It has also been described as a "psychotropic" and antidepressant.^[3] An analogue of gludantan, N-3,5-dimethylgludantan, is an inactive metabolite of memantine.^[4][5] Gludantan was developed in the Soviet Union and was first described by 1974.^[6][2]

Other namesGludantane; N-Adamantan-1-yl-β-D-glucopyranuronosylamine

CAS Number

• 12707-95-8

PubChem CID

• 9996542

PubChemSID

• 274134074

Quick facts Clinical data, Other names ...

Gludantan

Clinical data
Other names	Gludantane; N-Adamantan-1-yl-β-D-glucopyranuronosylamine
Identifiers
IUPAC name (2S,3S,4S,5R,6R)-6-(1-adamantylamino)-3,4,5-trihydroxyoxane-2-carboxylic acid
CAS Number	12707-95-8
PubChem CID	9996542
PubChem SID	274134074
ChemSpider	8172123
Chemical and physical data
Formula	C16H25NO6
Molar mass	327.377 g·mol−1
3D model (JSmol)	Interactive image
SMILES C1C2CC3CC1CC(C2)(C3)N[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)O)O)O)O
InChI InChI=1S/C16H25NO6/c18-10-11(19)13(15(21)22)23-14(12(10)20)17-16-4-7-1-8(5-16)3-9(2-7)6-16/h7-14,17-20H,1-6H2,(H,21,22)/t7?,8?,9?,10-,11-,12+,13-,14+,16?/m0/s1 Key:CORMWKGBVDLTGH-KIBBNWRDSA-N

Close